Cybin Inc. Common Stock (HELP) Stock Ticker
HELP right now
Market factors today
Unlock the full HELP picture
About Cybin Inc. Common Stock
Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
HELP stock facts
| Ticker symbol | HELP |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| Market cap | $781.6M |
| CEO | Michael I. Halstead |
| Employees | 100 |
| Headquarters | Toronto, ON, CA |
| IPO date | 2019-09-13 |
| Website | www.helus.com |
What you can see for HELP on Tickr
Live HELP price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the HELP report.
Rankings
FAQ
What is the ticker symbol for Cybin Inc. Common Stock?
The ticker symbol for Cybin Inc. Common Stock is HELP, listed on the NASDAQ Global Market.
What is HELP?
Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized…